Cohen Cheryl
SEC insider (Form 3/4/5 filer). CIK 0001529371. Director at ImmunityBio, Inc. (IBRX) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in SAN DIEGO, CA.
Companies Cohen Cheryl has filed insider reports for
- ImmunityBio, Inc. (IBRX): Director
- Celldex Therapeutics, Inc. (CLDX): Director
Cohen Cheryl
CIK: 0001529371
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 2, 2026IBRX
ImmunityBio, Inc.
ExerciseDirect56K shares at avg. $2.98$167K - Oct 2, 2026IBRX
ImmunityBio, Inc.
SaleDirect81.1K shares at avg. $10.50$851K - Jul 2, 2026IBRX
ImmunityBio, Inc.
ExerciseDirect56K shares at avg. $2.98$167K - Jul 2, 2026IBRX
ImmunityBio, Inc.
SaleDirect131.2K shares at avg. $9.50$1.2M - Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
26K shares- - Jun 9, 2026IBRX
ImmunityBio, Inc.
AwardDirectStock Option (right to buy)
65.6K shares- - Jun 18, 2025IBRX
ImmunityBio, Inc.
AwardDirectStock Option (right to buy)
162.8K shares- - Jun 5, 2025CLDX
Celldex Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
16.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 |  IBRX ImmunityBio, Inc. | Exercise | 55,979 | $2.98 | $166,817 | Direct |
| Oct 2, 2026 | IBRX ImmunityBio, Inc. | Sale | 81,056 | $10.50 | $851,088 | Direct |
| Jul 2, 2026 | IBRX ImmunityBio, Inc. | Exercise | 55,979 | $2.98 | $166,817 | Direct |
| Jul 2, 2026 | IBRX ImmunityBio, Inc. | Sale | 131,210 | $9.50 | $1,246,941 | Direct |
| Jun 25, 2026 |  CLDX Celldex Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 26,000 | - | - | Direct |
| Jun 9, 2026 | IBRX ImmunityBio, Inc. | Award Stock Option (right to buy) | 65,600 | - | - | Direct |
| Jun 18, 2025 | IBRX ImmunityBio, Inc. | Award Stock Option (right to buy) | 162,786 | - | - | Direct |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 16,500 | - | - | Direct |
1-8 of 8 transactions